ConductScience.org, home

Paper33613554

An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer.

Yan H and 7 others. Front Immunol, 2020. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer. Papers, record 33613554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33613554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer.
PubMed
Journal
Front Immunol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.49
iCite
Revised in PubMed
2024-08-06
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yan HHongfei
2Chen YYang
3Yang ZZichang
4Li ZZhi
5Che XXiaofang
6Xiao JJiawen
7Liu YYunpeng
8Qu XXiujuan

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Chemotherapy, AdjuvantMajor topic
Stomach NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
B-Lymphocytes
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Databases, Factual
Databases, Genetic
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Killer Cells, Natural
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Staging
Prognosis
Proportional Hazards Models

Source PubMed

Download CSV of topics

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125894828Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.Nat Med2015https://conductscience.org/library/papers/25894828PubMed
217978289Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.N Engl J Med2007https://conductscience.org/library/papers/17978289PubMed
329620995
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.
J Clin Oncol2018https://conductscience.org/library/papers/29620995PubMed
430042208Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit.Clin Cancer Res2018https://conductscience.org/library/papers/30042208PubMed
525079317Comprehensive molecular characterization of gastric adenocarcinoma.Nature2014https://conductscience.org/library/papers/25079317PubMed
621444866Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.J Clin Oncol2011https://conductscience.org/library/papers/21444866PubMed
732294529Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study.Ann Oncol2020https://conductscience.org/library/papers/32294529PubMed
811547741Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.N Engl J Med2001https://conductscience.org/library/papers/11547741PubMed
924138885Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.Immunity2013https://conductscience.org/library/papers/24138885PubMed
1016822992Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.N Engl J Med2006https://conductscience.org/library/papers/16822992PubMed
1126075713Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.PLoS One2015https://conductscience.org/library/papers/26075713PubMed
1225638553Outcomes and endpoints in trials of cancer treatment: the past, present, and future.Lancet Oncol2015https://conductscience.org/library/papers/25638553PubMed
1328002059ImmunoScore Signature: A Prognostic and Predictive Tool in Gastric Cancer.Ann Surg2018https://conductscience.org/library/papers/28002059PubMed
148596936Enhancement of antitumor immunity by CTLA-4 blockade.Science1996https://conductscience.org/library/papers/8596936PubMed
1528238215Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer.J Clin Lab Anal2018https://conductscience.org/library/papers/28238215PubMed
1631615816Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer.Cancer Immunol Res2019https://conductscience.org/library/papers/31615816PubMed
1732264809Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer.Comb Chem High Throughput Screen2020https://conductscience.org/library/papers/32264809PubMed
1831315901Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients.Clin Chem2019https://conductscience.org/library/papers/31315901PubMed
1932209727Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma.Aging (Albany NY)2020https://conductscience.org/library/papers/32209727PubMed
2020808728Regularization Paths for Generalized Linear Models via Coordinate Descent.J Stat Softw2010https://conductscience.org/library/papers/20808728PubMed

See all 49 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42183189Immunoscore and beyond: evolution and clinical integration of immune contexture-based biomarkers across solid tumours.Front Immunol2026https://conductscience.org/library/papers/42183189PubMed
39802286Landscape of B lymphocytes and plasma cells in digestive tract carcinomas.Ann Gastroenterol2025https://conductscience.org/library/papers/39802286PubMed
38525439N6-methylation in the development, diagnosis, and treatment of gastric cancer.J Transl Int Med2024https://conductscience.org/library/papers/38525439PubMed
38077386The molecular mechanism of actions and clinical utilities of tumor infiltrating lymphocytes in gastrointestinal cancers: a comprehensive review and future prospects toward personalized medicine.Front Immunol2023https://conductscience.org/library/papers/38077386PubMed
36497422Gastric Cancer and the Immune System: The Key to Improving Outcomes?Cancers (Basel)2022https://conductscience.org/library/papers/36497422PubMed
35805132Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients.Cells2022https://conductscience.org/library/papers/35805132PubMed
35518357Dissecting the Role of Immune Checkpoint Regulation Patterns in Tumor Microenvironment and Prognosis of Gastric Cancer.Front Genet2022https://conductscience.org/library/papers/35518357PubMed
34422960SMOX expression predicts the prognosis of non-small cell lung cancer.Ann Transl Med2021https://conductscience.org/library/papers/34422960PubMed
34307129Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients.Front Oncol2021https://conductscience.org/library/papers/34307129PubMed

Download CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33613554

GET https://conductscience.org/api/papers/v1/33613554/references?page=2